Cancer organizations are urging researchers, oncologists, and other stakeholders to advocate for cancer research.

The FDA updated the ongoing H&C Farms tomato recall to Class I, reflecting a high risk of salmonella infection.

The risk for COVID-19-related hospitalization was not significantly different between vaccinated older adults with vs without age-restrictive access to nirmatrelvir-ritonavir.

Among the 43 evaluable patients treated with sevabertinib, the confirmed objective response rate was 72.1%.

Certain air pollutants were associated with changes in metabolites among postmenopausal women in the US, potentially impacting bone health.

Colorado has reported 11 cases, including one 3-case outbreak, in relation to the 1088-case nationwide spread of measles in 2025.

Vaping persistence rates were lower in adolescents who used oral nicotine products including nicotine pouches.

Pediatric community-acquired pneumonia severity can be predicted accurately with 7 factors based on a new model.

RSV seasons ended earlier than usual in 2022-23 and 2023-24, and typical human hMPV circulation patterns have returned since the COVID-19 pandemic.

The FDA has approved Nucala (mepolizumab) for the add-on maintenance treatment of patients with inadequately controlled eosinophilic COPD.

Pediatric patients exhibited high risk for severe avian influenza A/H5N1, suggesting clinical therapeutic and vaccine trials should be prioritized in this population.

Maternal vaccination and, to a lesser extent, nirsevimab appear to significantly reduce RSV-related hospitalizations in infants.